Google Maps

Platform

Home
Studies

Other

Terms of Service
Privacy Policy

Workspace

Terms of Service

Studies
Azithromycin in Atopic Dermatitis

NCT07713186

Overview

NCT ID: NCT07713186
Lead Sponsor: Cairo UniversityOTHER
Official Title: Evaluation of the Value of Adding Azithromycin to Topical Treatment in Mild to Moderate Atopic Dermatitis
Brief Summary: The study will evaluate the role of adding azithromycin to topical treatment in patients with mild to moderate atopic dermatitis
Conditions: Atopic Dermatitis
Interventions: Betamethasone or tacrolimus ointments
Azithromycin

Status and Timeline

Status: Not yet recruiting
Last Update Posted: Jul 20, 2026Actual
Start Date: Aug 1, 2026Estimated
Primary Completion Date: Jan 2027Estimated
Completion Date

Participation Criteria

Ages Eligible for Study: Child (0-17)
Sexes Eligible for Study: All
Accepts Healthy Volunteers?: No
Eligibility Criteria: Inclusion Criteria:

Both genders, ages from 3 to 12 years old with mild to moderate atopic dermatitis

Exclusion Criteria:

Atopic dermatitis on active systemic treatment

Study Plan

Study Type: Interventional
Phase: Phase 4
Enrollment: 40Estimated
Primary Purpose: Treatment
Allocation: Randomized
Interventional Model: Parallel Assignment
Masking: Double

Contacts and Locations

Central Contacts: Amira Elbendary, MDContact
aelbendary@kasralainy.edu.eg+201552208664

Similar Studies

On this page

Overview
Status and Timeline
Participation Criteria
Study Plan
Contacts and Locations
Similar Studies

Quick actions

ClinicalTrials.gov

Jan 2027Estimated

Masking Description

No data available

Observational Model

No data available

Time Perspective

No data available

Participant Group/Arms

Topical corticosteroids and tacrolimusActive Comparator

Atopic dermatitis patients on topical betamethasone and tacrolimus ointments

Drug: Betamethasone or tacrolimus ointments

AzithromycinExperimental

Atopic dermatitis treated with azithromycin besides topical betamethasone and tacrolimus ointments

Drug: Betamethasone or tacrolimus ointments

Locations

Cairo University

Cairo, Saray 11562, Egypt

Amira Elbendary, MDContact

aelbendary@kasralainy.edu.eg+201555668584

Drug: Azithromycin

Azithromycin in Atopic Dermatitis | NCT07713186 | Trialant

NCT01447381Unknown status

Systemic Therapies for Pediatric Atopic Dermatitis

NCT01429701Completed

Effectiveness of Polymyxin B Sulphate + Prednisolone + Benzocaine + Clioquinol in Acute and Sub-acute Dermatitis Eczematous

NCT02865356Completed

Topical Solution for the Treatment of Atopic Dermatitis

NCT05969730Completed

Baricitinib Versus Azathioprine in Patients With Moderate-to-Severe Atopic Dermatitis

NCT01631617Recruiting

Effects of Treatments on Atopic Dermatitis

NCT07367932Not yet recruiting

Comparative Study of Crisaborole vs. Tacrolimus in Atopic Dermatitis

NCT05324618Completed

Tacrolimus Versus Hydrocortisone in Atopic Dermatitis

NCT07519174Not yet recruiting

A Randomized Controlled Trial Comparing the Effectiveness and Safety of Topical Tacrolimus 0.03% Versus Crisaborole 2% in Patients With Mild to Moderate Atopic Dermatitis Over 8 Weeks